Vinca Alkaloid Active Pharmaceutical Ingredient (API) Global Market Report 2025
상품코드:1760737
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 175 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
빈카 알칼로이드 원료의약품(API) 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년까지 연평균 복합 성장률(CAGR) 7.4%로 18억 달러에 달할 것으로 예측됩니다. 예측 기간 동안 성장의 원동력은 소아암 유병률 증가, 비용 효율적인 화학요법에 대한 수요 증가, 최소 침습적 암 치료에 대한 강조, 수의학 암학에서 빈카 알칼로이드의 사용 확대, 암 치료제 파이프라인 증가입니다. 예측 기간 동안 주요 동향으로는 반합성 생산 기술의 발전, 독성을 줄인 고급 제제 개발, 빈카 알칼로이드의 표적 전달 혁신, 암 치료제 개발에 인공지능(AI)의 통합, 암 치료제 전문 위탁 생산의 발전 등을 꼽을 수 있습니다.
암 발병률 증가는 향후 몇 년 동안 빈카 알칼로이드 원료의약품(API) 시장의 성장을 견인할 것으로 예측됩니다. 암은 비정상적인 세포의 무질서한 증식과 확산이 특징이며, 고령화로 인해 확산되고 있습니다. 나이가 들어감에 따라 유전자 변이가 축적되고 면역 기능이 저하되어 암 발생 위험이 높아집니다. 빈카 알칼로이드 원약은 세포분열을 억제하여 빠르게 성장하는 종양에 효과를 발휘하여 암 치료에 중요한 역할을 하고 있습니다. 이러한 API는 미세혈관을 표적으로 하여 화학요법 요법을 강화하여 치료 성적을 향상시킵니다. 예를 들어, 호주 보건 복지 연구소에 따르면 2024년 7월 호주에서 2022년 암 진단 건수는 16,570건으로 2021년 대비 3,789건 증가했다고 합니다. 따라서 암 발병률 증가는 빈카 알칼로이드 원료의약품(API) 시장의 성장을 주도하고 있습니다.
헬스케어 지출 증가는 빈카 알칼로이드 API 시장의 성장을 가속할 것으로 예측됩니다. 헬스케어 지출은 의료 서비스, 치료, 연구, 건강 상태를 유지 및 개선하기 위한 공중 보건 노력에 대한 총 지출을 의미합니다. 의료 서비스에 대한 수요 증가는 주로 고가의 장기 치료가 필요한 암과 같은 만성 질환에 대한 부담 증가로 인해 발생합니다. 의료비 지출 증가는 빈카 알칼로이드 원료의약품의 생산과 연구에 자금을 지원하여 필수적인 암 치료제공급을 보장하는 데 도움이 되고 있습니다. 이러한 투자는 제제 기술 혁신을 촉진하고, 치료 결과의 개선과 맞춤형 의료의 진보를 가져옵니다. 예를 들어, 미국 메디케어 및 메디케이드 서비스 센터(CMS)에 따르면, 미국의 국민 의료비는 2023년 7.5% 증가한 4조 9,000억 달러로 GDP의 17.6%를 차지할 것으로 예상했습니다. 의료비 지출은 2023년부터 2032년까지 연평균 5.6%의 성장률을 보일 것으로 예측되며, 이는 빈카 알칼로이드 원료의약품(API) 시장을 더욱 뒷받침할 것으로 전망됩니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나재난과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계 빈카 알칼로이드 원료의약품 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 빈카 알칼로이드 원료의약품(API) 시장 : 성장률 분석
세계의 빈카 알칼로이드 원료의약품(API) 시장 실적 : 규모와 성장, 2019-2024
세계의 빈카 알칼로이드 원료의약품(API) 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계 빈카 알칼로이드 원료의약품 전체 시장(TAM)
제6장 시장 세분화
세계의 빈카 알칼로이드 원료의약품(API) 시장 : 빈카 알칼로이드 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
Vincristine
Vinblastine
Vindesine
Vinorelbine
기타 유형 빈카 알칼로이드
세계의 빈카 알칼로이드 원료의약품(API) 시장 : 처방 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
무균 제제
비멸균 제제
세계의 빈카 알칼로이드 원료의약품(API) 시장 : 용도별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
폐암
유방암
림프종
기타 용도
세계의 빈카 알칼로이드 원료의약품(API) 시장 : 최종사용자별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
제약회사
연구기관
계약 개발 제조 조직(CDMO)
종양학 클리닉
세계의 빈카 알칼로이드 원료의약품(API) 시장 빈크리스틴 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
빈크리스틴 황산염 주사제
경구용 빈크리스틴 황산염
빈크리스틴 황산염 주사제(동결건조)
세계의 빈카 알칼로이드 원료의약품(API) 시장 빈브라스틴 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
세계의 빈카 알칼로이드 원료의약품(API) 시장 비노레르빈 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
비노렐빈 타르타르산염 주사
비노렐빈 타르타르산염 경구용 캡슐
세계의 빈카 알칼로이드 원료의약품(API) 시장, 기타 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
빈크리스틴 유사체
빈브라스틴 유사체
기타 빈카 알칼로이드
제7장 지역별/국가별 분석
세계의 빈카 알칼로이드 원료의약품(API) 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
세계의 빈카 알칼로이드 원료의약품(API) 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
빈카 알칼로이드 원료의약품(API) 시장 : 경쟁 구도
빈카 알칼로이드 원료의약품(API) 시장 : 기업 개요
Pfizer Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Eli Lilly and Company : 개요, 제품 및 서비스, 전략 및 재무 분석
Teva Pharmaceutical Industries Ltd. : 개요, 제품 및 서비스, 전략 및 재무 분석
Fresenius Kabi AG : 개요, 제품 및 서비스, 전략 및 재무 분석
Gedeon Richter Plc : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Zhejiang Hisun Pharmaceutical Co. Ltd.
Pierre Fabre Laboratories
Qilu Pharmaceutical Co. Ltd.
Minakem SAS
Taj Pharmaceuticals Ltd.
Naprod Life Sciences Pvt. Ltd.
Guangzhou Hanfang Pharmaceutical Co. Ltd.
ChemWerth Inc.
Transo-Pharm USA LLC
Sun Pharmaceutical Industries Ltd.
Avanscure Lifesciences Private Limited
Zeon Pharma Industries India Private Limited
Heet Healthcare Pvt. Ltd.
Hubei Honch Pharmaceutical Co. Ltd.
Hainan Periwinkle Pharmaceutical Co. Ltd.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
빈카 알칼로이드 원료의약품(API) 시장(2029년) : 새로운 기회를 제공하는 국가
빈카 알칼로이드 원료의약품(API) 시장(2029년) : 새로운 기회를 제공하는 부문
빈카 알칼로이드 원료의약품(API) 시장(2029년) : 성장 전략
시장 동향에 근거한 전략
경쟁 전략
제36장 부록
LSH
영문 목차
영문목차
Vinca alkaloid active pharmaceutical ingredients (APIs) refer to biologically active compounds derived from the Vinca plant, used in cancer treatment drugs. These alkaloids function by disrupting the mitotic process in cancer cells, preventing them from dividing and proliferating, which makes them essential in chemotherapy treatments.
The main types of vinca alkaloid APIs include vincristine, vinblastine, vindesine, vinorelbine, and others. Vincristine is a vinca alkaloid chemotherapy drug derived from the Catharanthus roseus plant. It acts as an antimitotic agent by binding to tubulin and inhibiting microtubule formation, thus blocking cell division. The formulations are available in both sterile and non-sterile preparations. Applications include treating lung cancer, breast cancer, lymphoma, and other oncology-related conditions. The end users include pharmaceutical companies, research institutions, contract development and manufacturing organizations (CDMOs), and oncology clinics.
The vinca alkaloid active pharmaceutical ingredient (API) market research report is one of a series of new reports from The Business Research Company that provides vinca alkaloid active pharmaceutical ingredient (API) market statistics, including vinca alkaloid active pharmaceutical ingredient (API) industry global market size, regional shares, competitors with a vinca alkaloid active pharmaceutical ingredient (API) market share, detailed vinca alkaloid active pharmaceutical ingredient (API) market segments, market trends and opportunities, and any further data you may need to thrive in the vinca alkaloid active pharmaceutical ingredient (API) industry. This vinca alkaloid active pharmaceutical ingredient (API) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The vinca alkaloid active pharmaceutical ingredient (API) market size has grown strongly in recent years. It will grow from $1.25 billion in 2024 to $1.35 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth during the historical period can be attributed to improved access to healthcare infrastructure, increased government support for cancer care, greater availability of generic cancer active pharmaceutical ingredients (APIs), rising collaborations among pharmaceutical companies, and a growing prevalence of lifestyle-related cancers.
The vinca alkaloid active pharmaceutical ingredient (API) market size is expected to see strong growth in the next few years. It will grow to $1.80 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period is driven by the increasing prevalence of pediatric cancers, rising demand for cost-effective chemotherapy, a growing emphasis on minimally invasive cancer treatments, the expanding use of vinca alkaloids in veterinary oncology, and the increasing pipeline of oncology drugs. Key trends in the forecast period include advancements in semi-synthetic production techniques, development of advanced formulations with reduced toxicity, innovation in targeted delivery of vinca alkaloids, the integration of artificial intelligence (AI) in oncology drug discovery, and advancements in oncology-specific contract manufacturing.
The rising incidence of cancer is expected to drive the growth of the vinca alkaloid active pharmaceutical ingredient (API) market in the coming years. Cancer, characterized by the uncontrolled growth and spread of abnormal cells, is becoming more prevalent due to the aging population. As individuals age, they accumulate genetic mutations and experience a decline in immune function, increasing their risk of developing cancer. Vinca alkaloid APIs play a critical role in cancer treatment by disrupting cell division, making them effective against rapidly growing tumors. These APIs enhance chemotherapy regimens by targeting microtubules, improving treatment outcomes. For example, according to the Australian Institute of Health and Welfare, in July 2024, cancer diagnoses in Australia increased to 160,570 cases in 2022, up by 3,789 cases from 2021. The rising incidence of cancer is, therefore, driving the growth of the vinca alkaloid API market.
The increasing healthcare expenditure is also expected to propel the growth of the vinca alkaloid API market. Healthcare expenditure refers to the total spending on medical services, treatments, research, and public health initiatives to maintain or improve health outcomes. The rising demand for healthcare services is mainly driven by the growing burden of chronic diseases such as cancer, which require expensive, long-term treatments. Increased healthcare spending helps fund the production and research of vinca alkaloid APIs, ensuring the availability of essential cancer treatments. This investment drives innovation in drug formulations, resulting in improved therapeutic outcomes and advancements in personalized medicine. For instance, according to the Centers for Medicare & Medicaid Services (CMS), national health expenditures in the U.S. grew by 7.5% in 2023, reaching $4.9 trillion, which accounted for 17.6% of the country's GDP. It is projected that healthcare spending will continue to grow at an average annual rate of 5.6% from 2023 to 2032, further supporting the vinca alkaloid API market.
Companies operating in the vinca alkaloid API market are also focusing on developing advanced formulations to improve patient compliance and enhance treatment efficacy. One such advancement is the use of soft gel capsules, which help increase drug absorption and extend product life cycles. In December 2022, Adalvo Limited, a Malta-based pharmaceutical company, launched Vinorelbine soft gel capsules. Derived from the reference brand NAVELBINE, this formulation is used to treat non-small cell lung cancer and advanced breast cancer. By offering more convenient dosing options, soft gel capsules aim to improve treatment accessibility and patient compliance.
Major players in the vinca alkaloid active pharmaceutical ingredient (api) market are Pfizer Inc., Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Fresenius Kabi AG, Gedeon Richter Plc, Zhejiang Hisun Pharmaceutical Co. Ltd., Pierre Fabre Laboratories, Qilu Pharmaceutical Co. Ltd., Minakem SAS, Taj Pharmaceuticals Ltd., Naprod Life Sciences Pvt. Ltd., Guangzhou Hanfang Pharmaceutical Co. Ltd., ChemWerth Inc., Transo-Pharm USA LLC, Sun Pharmaceutical Industries Ltd., Avanscure Lifesciences Private Limited, Zeon Pharma Industries India Private Limited, Heet Healthcare Pvt. Ltd., Hubei Honch Pharmaceutical Co. Ltd., Hainan Periwinkle Pharmaceutical Co. Ltd.
North America was the largest region in the vinca alkaloid active pharmaceutical ingredient (API) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in vinca alkaloid active pharmaceutical ingredient (API) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the vinca alkaloid active pharmaceutical ingredient (API) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The vinca alkaloid active pharmaceutical ingredient (API) market consists of sales of leurocristine, episil, desacetylvinblastine, catharanthine, and vinflunine. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Vinca Alkaloid Active Pharmaceutical Ingredient (API) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on vinca alkaloid active pharmaceutical ingredient (api) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for vinca alkaloid active pharmaceutical ingredient (api) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The vinca alkaloid active pharmaceutical ingredient (api) market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type Of Vinca Alkaloid: Vincristine; Vinblastine; Vindesine; Vinorelbine; Other Types Of Vinca Alkaloid
2) By Formulation Type: Sterile Formulations; Non-Sterile Formulations
3) By Application: Lung Cancer; Breast Cancer; Lymphoma; Other Applications
4) By End User: Pharmaceutical Companies; Research Institutions; Contract Development And Manufacturing Organizations (CDMOs); Oncology Clinics
Subsegments:
1) By Vincristine: Vincristine Sulfate Injection; Vincristine Sulfate For Oral Use; Vincristine Sulfate For Injection, Lyophilized
2) By Vinblastine: Vinblastine Sulfate Injection; Vinblastine Sulfate Oral Tablets; Vinblastine Sulfate For Injection, Lyophilized
3) By Vindesine: Vindesine Sulfate Injection; Vindesine Sulfate For Oral Use
4) By Vinorelbine: Vinorelbine Tartrate Injection; Vinorelbine Tartrate Oral Capsules
5) By Other Types: Vincristine Analogues; Vinblastine Analogues; Other Vinca Alkaloids
Companies Mentioned: Pfizer Inc.; Eli Lilly and Company; Teva Pharmaceutical Industries Ltd.; Fresenius Kabi AG; Gedeon Richter Plc
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market Characteristics
3. Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market Trends And Strategies
4. Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Vinca Alkaloid Active Pharmaceutical Ingredient (API) Growth Analysis And Strategic Analysis Framework
5.1. Global Vinca Alkaloid Active Pharmaceutical Ingredient (API) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market Growth Rate Analysis
5.4. Global Vinca Alkaloid Active Pharmaceutical Ingredient (API) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Vinca Alkaloid Active Pharmaceutical Ingredient (API) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Vinca Alkaloid Active Pharmaceutical Ingredient (API) Total Addressable Market (TAM)
6. Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market Segmentation
6.1. Global Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Type Of Vinca Alkaloid, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Vincristine
Vinblastine
Vindesine
Vinorelbine
Other Types Of Vinca Alkaloid
6.2. Global Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Sterile Formulations
Non-Sterile Formulations
6.3. Global Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Lung Cancer
Breast Cancer
Lymphoma
Other Applications
6.4. Global Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharmaceutical Companies
Research Institutions
Contract Development And Manufacturing Organizations (CDMOs)
Oncology Clinics
6.5. Global Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Sub-Segmentation Of Vincristine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Vincristine Sulfate Injection
Vincristine Sulfate For Oral Use
Vincristine Sulfate For Injection, Lyophilized
6.6. Global Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Sub-Segmentation Of Vinblastine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Vinblastine Sulfate Injection
Vinblastine Sulfate Oral Tablets
Vinblastine Sulfate For Injection, Lyophilized
6.7. Global Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Sub-Segmentation Of Vindesine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Vindesine Sulfate Injection
Vindesine Sulfate For Oral Use
6.8. Global Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Sub-Segmentation Of Vinorelbine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Vinorelbine Tartrate Injection
Vinorelbine Tartrate Oral Capsules
6.9. Global Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Vincristine Analogues
Vinblastine Analogues
Other Vinca Alkaloids
7. Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market Regional And Country Analysis
7.1. Global Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market
8.1. Asia-Pacific Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Type Of Vinca Alkaloid, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market
9.1. China Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market Overview
9.2. China Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Type Of Vinca Alkaloid, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market
10.1. India Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Type Of Vinca Alkaloid, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market
11.1. Japan Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market Overview
11.2. Japan Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Type Of Vinca Alkaloid, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market
12.1. Australia Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Type Of Vinca Alkaloid, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market
13.1. Indonesia Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Type Of Vinca Alkaloid, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market
14.1. South Korea Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market Overview
14.2. South Korea Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Type Of Vinca Alkaloid, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market
15.1. Western Europe Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market Overview
15.2. Western Europe Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Type Of Vinca Alkaloid, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market
16.1. UK Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Type Of Vinca Alkaloid, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market
17.1. Germany Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Type Of Vinca Alkaloid, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market
18.1. France Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Type Of Vinca Alkaloid, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market
19.1. Italy Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Type Of Vinca Alkaloid, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market
20.1. Spain Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Type Of Vinca Alkaloid, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market
21.1. Eastern Europe Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market Overview
21.2. Eastern Europe Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Type Of Vinca Alkaloid, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market
22.1. Russia Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Type Of Vinca Alkaloid, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market
23.1. North America Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market Overview
23.2. North America Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Type Of Vinca Alkaloid, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market
24.1. USA Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market Overview
24.2. USA Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Type Of Vinca Alkaloid, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market
25.1. Canada Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market Overview
25.2. Canada Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Type Of Vinca Alkaloid, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market
26.1. South America Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market Overview
26.2. South America Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Type Of Vinca Alkaloid, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market
27.1. Brazil Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Type Of Vinca Alkaloid, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market
28.1. Middle East Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market Overview
28.2. Middle East Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Type Of Vinca Alkaloid, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market
29.1. Africa Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market Overview
29.2. Africa Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Type Of Vinca Alkaloid, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market Competitive Landscape And Company Profiles
30.1. Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market Competitive Landscape
30.2. Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market Company Profiles
30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Gedeon Richter Plc Overview, Products and Services, Strategy and Financial Analysis
31. Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market Other Major And Innovative Companies
31.1. Zhejiang Hisun Pharmaceutical Co. Ltd.
31.2. Pierre Fabre Laboratories
31.3. Qilu Pharmaceutical Co. Ltd.
31.4. Minakem SAS
31.5. Taj Pharmaceuticals Ltd.
31.6. Naprod Life Sciences Pvt. Ltd.
31.7. Guangzhou Hanfang Pharmaceutical Co. Ltd.
31.8. ChemWerth Inc.
31.9. Transo-Pharm USA LLC
31.10. Sun Pharmaceutical Industries Ltd.
31.11. Avanscure Lifesciences Private Limited
31.12. Zeon Pharma Industries India Private Limited
31.13. Heet Healthcare Pvt. Ltd.
31.14. Hubei Honch Pharmaceutical Co. Ltd.
31.15. Hainan Periwinkle Pharmaceutical Co. Ltd.
32. Global Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market
34. Recent Developments In The Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market
35. Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market High Potential Countries, Segments and Strategies
35.1 Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market In 2029 - Countries Offering Most New Opportunities
35.2 Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market In 2029 - Segments Offering Most New Opportunities
35.3 Vinca Alkaloid Active Pharmaceutical Ingredient (API) Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer
(주)글로벌인포메이션02-2025-2992kr-info@giikorea.co.kr ⓒ Copyright Global Information, Inc. All rights reserved.
